Skip to main content
. 2017 Oct 31;5(12):2025–2027. doi: 10.1002/ccr3.1221

Figure 1.

Figure 1

Successful treatment of severe PG caused by MDS by a noncytotoxic regimen of decitabine to deplete DNMT1. (A) The ulcer pretreatment. (B) Treatment induced increase in platelet count consistent with noncytotoxic differentiation‐restoring mode of action. (C) The ulcer after 20 weeks of therapy.